Today news
The same in other media
07.06 - 22:53
07.06 - 22:53
US COVID-19 deaths pass 90,000 as Moderna vaccine delivers promising phase 1 results
Reading now: 680
Moderna's COVID-19 vaccine candidate appears safe for human use, the company said today as it released results from the phase 1 trial of mRNA-1273.The dose-dependent trial sets the stage for a phase 2 trial, expected to start shortly and a larger phase 3 trial which will begin in July.
The phase 1 trail showed an immune response in a small number healthy adult participants (8), who produced neutralizing antibodies to the virus that were similar to the antibodies seen in convalescent COVID-19 patient's plasma."With today's positive interim phase 1 data and the positive data in the mouse challenge model, the Moderna team continues to focus on moving as fast as safely possible to start our pivotal phase 3 study in July and, if successful, file
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|